PROPERTIES OF INCORPORATION, REDISTRIBUTION, AND INTEGRITY OF PORPHYRIN LOW-DENSITY-LIPOPROTEIN COMPLEXES

被引:51
作者
DESMIDT, PC [1 ]
VERSLUIS, AJ [1 ]
VANBERKEL, TJC [1 ]
机构
[1] LEIDEN UNIV, SYLVIUS LAB,CTR BIOPHARMACEUT SCI, DIV BIOPHARMACEUT,POB 9503, 2300 RA LEIDEN, NETHERLANDS
关键词
D O I
10.1021/bi00062a023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the photodynamic therapy of cancer, research has focused on the influence of lipoproteins (particularly the low-density lipoprotein, LDL) on the fate and transport of the porphyrin mixture. We have studied the interaction between LDL and a series of well-defined tetraphenylporphinesulfonates, TPPS-1, TPPS-2A, and TPPS-4. Compounds with at least two unsulfonated phenyl groups were found to associate with LDL (TPPS-1 and TPPS-2A), whereas sulfonation of all four rings abolished lipoprotein binding. As shown with agarose gel electrophoresis, association of doubly charged TPPS-2A molecules with LDL strongly influences LDL's charge. Because a change in charge may alter LDL's biological behavior, the effect of increasing amounts of TPPS-2A molecules per LDL on its biological reactivity was examined. In vitro studies with Hep G2 cells indicated that up to 250 molecules of TPPS-2A per LDL left LDL receptor recognition unchanged. In vivo studies on the fate of I-125-LDL-TPPS-2A particles in rats showed that complexes with molar ratios up to 1:100 were processed like native LDL. It is concluded that tetraphenylporphines of a partial hydrophilic-hydrophobic nature are most optimal for spontaneous association with lipoproteins. These porphyrin structures will utilize lipoproteins as biological transport vehicles whereby up to 100 molecules per lipoprotein particle will not change the biological behavior of the particles so that LDL receptor-dependent uptake by tumor cells under these conditions is warranted.
引用
收藏
页码:2916 / 2922
页数:7
相关论文
共 29 条
[1]   ROLE OF HIGH-DENSITY, LOW-DENSITY AND VERY LOW-DENSITY LIPOPROTEINS IN THE TRANSPORT AND TUMOR-DELIVERY OF HEMATOPORPHYRIN INVIVO [J].
BAREL, A ;
JORI, G ;
PERIN, A ;
ROMANDINI, P ;
PAGNAN, A ;
BIFFANTI, S .
CANCER LETTERS, 1986, 32 (02) :145-150
[2]   METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS [J].
BILHEIMER, DW ;
LEVY, RI ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :212-+
[3]   INVITRO INTERACTION OF THE PHOTOACTIVE ANTICANCER PORPHYRIN DERIVATIVE PHOTOFRIN-II WITH LOW-DENSITY-LIPOPROTEIN, AND ITS DELIVERY TO CULTURED HUMAN-FIBROBLASTS [J].
CANDIDE, C ;
MORLIERE, P ;
MAZIERE, JC ;
GOLDSTEIN, S ;
SANTUS, R ;
DUBERTRET, L ;
REYFTMANN, JP ;
POLONOVSKI, J .
FEBS LETTERS, 1986, 207 (01) :133-138
[4]   EVANS BLUE SPACE IN TISSUES OF THE RAT [J].
CASTER, WO ;
SIMON, AB ;
ARMSTRONG, WD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1955, 183 (02) :317-321
[5]   LIPOPROTEINS AS POTENTIAL SITE-SPECIFIC DELIVERY SYSTEMS FOR DIAGNOSTIC AND THERAPEUTIC AGENTS [J].
COUNSELL, RE ;
POHLAND, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (10) :1115-1120
[6]  
CRAIG IF, 1982, J BIOL CHEM, V257, P330
[7]  
DESMIDT PC, 1990, CANCER RES, V50, P7476
[8]   CELLULAR-LOCALIZATION OF THE RECEPTOR-DEPENDENT AND RECEPTOR-INDEPENDENT UPTAKE OF HUMAN LDL IN THE LIVER OF NORMAL AND 17-ALPHA-ETHINYL ESTRADIOL-TREATED RATS [J].
HARKES, L ;
VANBERKEL, TJC .
FEBS LETTERS, 1983, 154 (01) :75-80
[9]   STIMULATION OF THE LDL RECEPTOR ACTIVITY IN THE HUMAN HEPATOMA-CELL LINE HEP G2 BY HIGH-DENSITY SERUM FRACTIONS [J].
HAVEKES, LM ;
SCHOUTEN, D ;
DEWIT, ECM ;
COHEN, LH ;
GRIFFIOEN, M ;
VANHINSBERGH, VWM ;
PRINCEN, HMG .
BIOCHIMICA ET BIOPHYSICA ACTA, 1986, 875 (02) :236-246
[10]   INTERACTIONS OF STEROIDS WITH SERUM-LIPOPROTEINS [J].
HOBBELEN, PM ;
COERT, A ;
GEELEN, JAA ;
VANDERVIES, J .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (12) :165-172